Providing researchers with the right information at the right time is a way pharmaceutical companies focused on new therapeutic solutions can advance product development. But when copyright compliance for a global workforce is factored in, accessing, and collaborating on that scientific information can become tricky.
BIAL faced four key challenges when it came to managing information across the enterprise: speed, accuracy, coverage, and availability.
To combat these challenges, BIAL secured a Multinational Copyright License, so employees could collaborate with team members, store articles for later use, provide required information to regulatory officials, and make it easy for employees to remain compliant.
Alongside internal research, BIAL also wanted to have the legal ability to collaborate with external teammates when doing a joint project. That’s why, in addition to the Multinational License, BIAL utilizes the Collaboration Amendment, a complimentary add-on that allows collaboration under the terms and conditions of the license among those team members of two licensed organizations who are working together on a joint project.